Perimenopausal Testosterone Replacement Therapy

Perimenopausal Testosterone Replacement Therapy May Provide These Health Benefits
Understanding the Treatment.
About Perimenopausal Testosterone Replacement Therapy
Yes. A woman’s testosterone can begin to decline before menopause, which for some contributes to reduced libido, energy, or focus during perimenopause. Low-dose testosterone therapy may be considered alongside estrogen and progesterone support. Revibe’s providers assess your labs and symptoms first.
The strongest evidence supports low-dose testosterone for distressing low sexual desire; evidence for treating fatigue, mood, or focus specifically is currently insufficient. Your Revibe provider sets realistic expectations based on this.
Doses are much lower than for men and aim to keep testosterone within the normal female range. Lab monitoring guides dosing so levels don’t rise too high.
It’s typically provided in low-dose topical or compounded forms, individualized to your labs and goals as directed by your provider.
Generally no it’s used as one component of a comprehensive perimenopausal hormone plan rather than in isolation. Your Revibe provider will coordinate it with your other programmed therapy.
Safety and Side Effects
No. There is no FDA-approved testosterone product for women in the U.S., so this is an off-label, provider-directed use at low doses. Your Revibe Health provider will explain this before prescribing.
Excess testosterone can cause acne, unwanted hair growth, or voice changes; physiologic dosing and monitoring minimize these. Report any side effects to your provider.
It’s generally avoided in women who are pregnant or breastfeeding, have hormone-sensitive cancers, or have certain other conditions. A full Revibe Health evaluation determines whether it’s right for you.






